Eugenia Abella Selected Research

Eugenia Abella Research Topics

Disease

5	Multiple Myeloma 12/2022 - 05/2019
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 01/2015
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 01/2008
3	Neoplasms (Cancer) 12/2022 - 06/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2019 - 02/2008
3	Philadelphia Chromosome 01/2019 - 10/2012
3	Hodgkin Disease (Hodgkin's Disease) 10/2009 - 09/2002
2	Plasmacytoma 01/2022 - 05/2019
2	Lymphoma (Lymphomas) 03/2011 - 02/2008
2	Infections 10/2009 - 10/2008
1	Smoldering Multiple Myeloma 12/2022
1	COVID-19 12/2022
1	Monoclonal Gammopathy of Undetermined Significance 12/2022
1	Respiratory Insufficiency (Respiratory Failure) 09/2019
1	Cardiotoxicity 06/2019
1	Disease Progression 03/2019
1	Lymphocytosis 01/2018
1	HIV Infections (HIV Infection) 04/2015
1	Leukemia 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2011
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2008
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 02/2008
1	Pathologic Complete Response 02/2007
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2006

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 12/2013 - 02/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013 - 01/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2011 - 02/2007
3	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2013 - 01/2008
3	fludarabineIBA 12/2013 - 01/2008
2	daratumumabIBA 01/2022 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2019 - 05/2019
2	pro-brain natriuretic peptide (1-76)IBA 06/2019 - 06/2011
2	Asparaginase (Elspar)FDA Link 01/2018 - 02/2007
2	AntigensIBA 01/2018 - 01/2006
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2009 - 02/2007
2	Dacarbazine (DIC)FDA LinkGeneric 10/2009 - 02/2007
2	Vinblastine (Vinblastine Sulfate)FDA Link 10/2009 - 02/2007
2	Prednisone (Sone)FDA LinkGeneric 02/2008 - 02/2007
2	Vincristine (Oncovin)FDA LinkGeneric 02/2008 - 02/2007
1	Messenger RNA (mRNA)IBA 12/2022
1	VaccinesIBA 12/2022
1	Bortezomib (Velcade)FDA Link 09/2019
1	AnthracyclinesIBA 06/2019
1	Natriuretic PeptidesIBA 06/2019
1	pomalidomideIBA 05/2019
1	ParaproteinsIBA 05/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	pegaspargase (Oncaspar)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 07/2017
1	Complementary DNA (cDNA)IBA 07/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 10/2012
1	Biomarkers (Surrogate Marker)IBA 06/2011
1	liposomal doxorubicin (Doxil)FDA Link 03/2011
1	Monoclonal AntibodiesIBA 09/2009
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2008
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 02/2007
1	Methotrexate (Mexate)FDA LinkGeneric 02/2007

Therapy/Procedure

7	Therapeutics 12/2022 - 02/2007
6	Drug Therapy (Chemotherapy) 01/2019 - 02/2007
4	Highly Active Antiretroviral Therapy (HAART) 04/2015 - 09/2002
1	Artificial Respiration (Mechanical Ventilation) 09/2019
1	Stem Cell Transplantation 10/2012
1	VAP-cyclo protocol 03/2011